These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20395112)

  • 41. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
    Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
    Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
    Johnstone S; Logan RM
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effects of vascular endothelial growth factor on dendritic cells in esophageal tumor tissue].
    Yang WF; Li DT; Li J; Chen XX; Wagn SZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):46-7, 55. PubMed ID: 17210106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
    Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
    Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
    Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
    Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
    Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
    Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
    Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
    Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis.
    Ohno F; Nakanishi H; Abe A; Seki Y; Kinoshita A; Hasegawa Y; Tatematsu M; Kurita K
    J Oral Pathol Med; 2007 May; 36(5):281-9. PubMed ID: 17448138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
    Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
    J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.
    Ding L; Hu EL; Xu YJ; Huang XF; Zhang DY; Li B; Hu QG; Ni YH; Hou YY
    Tumour Biol; 2015 Apr; 36(4):2523-9. PubMed ID: 25613064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance.
    Aggarwal S; Devaraja K; Sharma SC; Das SN
    Clin Chim Acta; 2014 Sep; 436():35-40. PubMed ID: 24833243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. VEGF-A immunohistochemical and mRNA expression in tissues and its serum levels in potentially malignant oral lesions and oral squamous cell carcinomas.
    Nayak S; Goel MM; Chandra S; Bhatia V; Mehrotra D; Kumar S; Makker A; Rath SK; Agarwal SP
    Oral Oncol; 2012 Mar; 48(3):233-9. PubMed ID: 22051188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
    Aggarwal S; Sharma SC; Das SN
    Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.
    Chang KP; Chang YT; Liao CT; Yen TC; Chen IH; Chang YL; Liu YL; Chang YS; Yu JS; Wu CC
    Clin Chim Acta; 2011 May; 412(11-12):980-7. PubMed ID: 21315702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
    Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
    Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of serum levels of vascular endothelial growth factor with TNM staging, histopathologic grading, and surgical therapy for oral squamous cell carcinoma.
    Jaiswal SG; Gadbail AR; Chaudhary MS; Jaiswal GR; Gawande M
    Quintessence Int; 2011 Oct; 42(9):771-9. PubMed ID: 21909502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.